Summary

The global Human Pain Management Drug market size is predicted to grow from US$ 79050 million in 2025 to US$ 105950 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.
Pain relievers, including acetaminophen, NSAIDs and opioids, can ease temporary aches and chronic pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Human Pain Management Drug Industry Forecast” looks at past sales and reviews total world Human Pain Management Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Pain Management Drug sales for 2026 through 2032. With Human Pain Management Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Pain Management Drug industry.
This Insight Report provides a comprehensive analysis of the global Human Pain Management Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Pain Management Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Pain Management Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Pain Management Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Pain Management Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Pain Management Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
OTC
Rx
Segmentation by Application:
Hospital
Retail Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie Inc. (Allergan plc)
Bristol Myers Squibb Co.
Sanofi S.A.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
GSK plc.
Abbott Laboratories, Inc.
Novartis AG
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Procter & Gamble
AstraZeneca
Cardinal Health
Perrigo Company Plc.
Bausch Health Companies Inc.
Viatris
Amneal Pharmaceuticals
Purdue Pharmaceuticals L.P.

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Pain Management Drug Market Size (2021-2032)
2.1.2 Human Pain Management Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Human Pain Management Drug by Country/Region (2021, 2025 & 2032)
2.2 Human Pain Management Drug Segment by Type
2.2.1 OTC
2.2.2 Rx
2.2.3 Human Pain Management Drug Market Size by Type
2.2.3.1 Human Pain Management Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Human Pain Management Drug Market Size Market Share by Type (2021-2026)
2.3 Human Pain Management Drug Segment by Application
2.3.1 Hospital
2.3.2 Retail Pharmacy
2.3.3 Other
2.3.4 Human Pain Management Drug Market Size by Application
2.3.4.1 Human Pain Management Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Human Pain Management Drug Market Size Market Share by Application (2021-2026)
3 Human Pain Management Drug Market Size by Player
3.1 Human Pain Management Drug Market Size Market Share by Player
3.1.1 Global Human Pain Management Drug Revenue by Player (2021-2026)
3.1.2 Global Human Pain Management Drug Revenue Market Share by Player (2021-2026)
3.2 Global Human Pain Management Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Pain Management Drug by Region
4.1 Human Pain Management Drug Market Size by Region (2021-2026)
4.2 Global Human Pain Management Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Pain Management Drug Market Size Growth (2021-2026)
4.4 APAC Human Pain Management Drug Market Size Growth (2021-2026)
4.5 Europe Human Pain Management Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Human Pain Management Drug Market Size Growth (2021-2026)
5 Americas
5.1 Americas Human Pain Management Drug Market Size by Country (2021-2026)
5.2 Americas Human Pain Management Drug Market Size by Type (2021-2026)
5.3 Americas Human Pain Management Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Pain Management Drug Market Size by Region (2021-2026)
6.2 APAC Human Pain Management Drug Market Size by Type (2021-2026)
6.3 APAC Human Pain Management Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Pain Management Drug Market Size by Country (2021-2026)
7.2 Europe Human Pain Management Drug Market Size by Type (2021-2026)
7.3 Europe Human Pain Management Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Pain Management Drug by Region (2021-2026)
8.2 Middle East & Africa Human Pain Management Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Human Pain Management Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Human Pain Management Drug Market Forecast
10.1 Global Human Pain Management Drug Forecast by Region (2027-2032)
10.1.1 Global Human Pain Management Drug Forecast by Region (2027-2032)
10.1.2 Americas Human Pain Management Drug Forecast
10.1.3 APAC Human Pain Management Drug Forecast
10.1.4 Europe Human Pain Management Drug Forecast
10.1.5 Middle East & Africa Human Pain Management Drug Forecast
10.2 Americas Human Pain Management Drug Forecast by Country (2027-2032)
10.2.1 United States Market Human Pain Management Drug Forecast
10.2.2 Canada Market Human Pain Management Drug Forecast
10.2.3 Mexico Market Human Pain Management Drug Forecast
10.2.4 Brazil Market Human Pain Management Drug Forecast
10.3 APAC Human Pain Management Drug Forecast by Region (2027-2032)
10.3.1 China Human Pain Management Drug Market Forecast
10.3.2 Japan Market Human Pain Management Drug Forecast
10.3.3 Korea Market Human Pain Management Drug Forecast
10.3.4 Southeast Asia Market Human Pain Management Drug Forecast
10.3.5 India Market Human Pain Management Drug Forecast
10.3.6 Australia Market Human Pain Management Drug Forecast
10.4 Europe Human Pain Management Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Human Pain Management Drug Forecast
10.4.2 France Market Human Pain Management Drug Forecast
10.4.3 UK Market Human Pain Management Drug Forecast
10.4.4 Italy Market Human Pain Management Drug Forecast
10.4.5 Russia Market Human Pain Management Drug Forecast
10.5 Middle East & Africa Human Pain Management Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Human Pain Management Drug Forecast
10.5.2 South Africa Market Human Pain Management Drug Forecast
10.5.3 Israel Market Human Pain Management Drug Forecast
10.5.4 Turkey Market Human Pain Management Drug Forecast
10.6 Global Human Pain Management Drug Forecast by Type (2027-2032)
10.7 Global Human Pain Management Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Human Pain Management Drug Forecast
11 Key Players Analysis
11.1 AbbVie Inc. (Allergan plc)
11.1.1 AbbVie Inc. (Allergan plc) Company Information
11.1.2 AbbVie Inc. (Allergan plc) Human Pain Management Drug Product Offered
11.1.3 AbbVie Inc. (Allergan plc) Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 AbbVie Inc. (Allergan plc) Main Business Overview
11.1.5 AbbVie Inc. (Allergan plc) Latest Developments
11.2 Bristol Myers Squibb Co.
11.2.1 Bristol Myers Squibb Co. Company Information
11.2.2 Bristol Myers Squibb Co. Human Pain Management Drug Product Offered
11.2.3 Bristol Myers Squibb Co. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bristol Myers Squibb Co. Main Business Overview
11.2.5 Bristol Myers Squibb Co. Latest Developments
11.3 Sanofi S.A.
11.3.1 Sanofi S.A. Company Information
11.3.2 Sanofi S.A. Human Pain Management Drug Product Offered
11.3.3 Sanofi S.A. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sanofi S.A. Main Business Overview
11.3.5 Sanofi S.A. Latest Developments
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Information
11.4.2 Boehringer Ingelheim International GmbH Human Pain Management Drug Product Offered
11.4.3 Boehringer Ingelheim International GmbH Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Boehringer Ingelheim International GmbH Main Business Overview
11.4.5 Boehringer Ingelheim International GmbH Latest Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Information
11.5.2 Pfizer Inc. Human Pain Management Drug Product Offered
11.5.3 Pfizer Inc. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Pfizer Inc. Main Business Overview
11.5.5 Pfizer Inc. Latest Developments
11.6 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
11.6.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Information
11.6.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Product Offered
11.6.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Main Business Overview
11.6.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Latest Developments
11.7 GSK plc.
11.7.1 GSK plc. Company Information
11.7.2 GSK plc. Human Pain Management Drug Product Offered
11.7.3 GSK plc. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 GSK plc. Main Business Overview
11.7.5 GSK plc. Latest Developments
11.8 Abbott Laboratories, Inc.
11.8.1 Abbott Laboratories, Inc. Company Information
11.8.2 Abbott Laboratories, Inc. Human Pain Management Drug Product Offered
11.8.3 Abbott Laboratories, Inc. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Abbott Laboratories, Inc. Main Business Overview
11.8.5 Abbott Laboratories, Inc. Latest Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Information
11.9.2 Novartis AG Human Pain Management Drug Product Offered
11.9.3 Novartis AG Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Novartis AG Main Business Overview
11.9.5 Novartis AG Latest Developments
11.10 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
11.10.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information
11.10.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Product Offered
11.10.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Main Business Overview
11.10.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Latest Developments
11.11 Sun Pharmaceutical Industries Ltd.
11.11.1 Sun Pharmaceutical Industries Ltd. Company Information
11.11.2 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Product Offered
11.11.3 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
11.11.5 Sun Pharmaceutical Industries Ltd. Latest Developments
11.12 Teva Pharmaceuticals Ltd.
11.12.1 Teva Pharmaceuticals Ltd. Company Information
11.12.2 Teva Pharmaceuticals Ltd. Human Pain Management Drug Product Offered
11.12.3 Teva Pharmaceuticals Ltd. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Teva Pharmaceuticals Ltd. Main Business Overview
11.12.5 Teva Pharmaceuticals Ltd. Latest Developments
11.13 Mallinckrodt Pharmaceuticals
11.13.1 Mallinckrodt Pharmaceuticals Company Information
11.13.2 Mallinckrodt Pharmaceuticals Human Pain Management Drug Product Offered
11.13.3 Mallinckrodt Pharmaceuticals Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Mallinckrodt Pharmaceuticals Main Business Overview
11.13.5 Mallinckrodt Pharmaceuticals Latest Developments
11.14 Endo Pharmaceuticals Inc.
11.14.1 Endo Pharmaceuticals Inc. Company Information
11.14.2 Endo Pharmaceuticals Inc. Human Pain Management Drug Product Offered
11.14.3 Endo Pharmaceuticals Inc. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Endo Pharmaceuticals Inc. Main Business Overview
11.14.5 Endo Pharmaceuticals Inc. Latest Developments
11.15 Bayer AG
11.15.1 Bayer AG Company Information
11.15.2 Bayer AG Human Pain Management Drug Product Offered
11.15.3 Bayer AG Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Bayer AG Main Business Overview
11.15.5 Bayer AG Latest Developments
11.16 F. Hoffmann-La Roche Ltd.
11.16.1 F. Hoffmann-La Roche Ltd. Company Information
11.16.2 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Product Offered
11.16.3 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.16.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.17 Procter & Gamble
11.17.1 Procter & Gamble Company Information
11.17.2 Procter & Gamble Human Pain Management Drug Product Offered
11.17.3 Procter & Gamble Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Procter & Gamble Main Business Overview
11.17.5 Procter & Gamble Latest Developments
11.18 AstraZeneca
11.18.1 AstraZeneca Company Information
11.18.2 AstraZeneca Human Pain Management Drug Product Offered
11.18.3 AstraZeneca Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 AstraZeneca Main Business Overview
11.18.5 AstraZeneca Latest Developments
11.19 Cardinal Health
11.19.1 Cardinal Health Company Information
11.19.2 Cardinal Health Human Pain Management Drug Product Offered
11.19.3 Cardinal Health Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Cardinal Health Main Business Overview
11.19.5 Cardinal Health Latest Developments
11.20 Perrigo Company Plc.
11.20.1 Perrigo Company Plc. Company Information
11.20.2 Perrigo Company Plc. Human Pain Management Drug Product Offered
11.20.3 Perrigo Company Plc. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Perrigo Company Plc. Main Business Overview
11.20.5 Perrigo Company Plc. Latest Developments
11.21 Bausch Health Companies Inc.
11.21.1 Bausch Health Companies Inc. Company Information
11.21.2 Bausch Health Companies Inc. Human Pain Management Drug Product Offered
11.21.3 Bausch Health Companies Inc. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Bausch Health Companies Inc. Main Business Overview
11.21.5 Bausch Health Companies Inc. Latest Developments
11.22 Viatris
11.22.1 Viatris Company Information
11.22.2 Viatris Human Pain Management Drug Product Offered
11.22.3 Viatris Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Viatris Main Business Overview
11.22.5 Viatris Latest Developments
11.23 Amneal Pharmaceuticals
11.23.1 Amneal Pharmaceuticals Company Information
11.23.2 Amneal Pharmaceuticals Human Pain Management Drug Product Offered
11.23.3 Amneal Pharmaceuticals Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Amneal Pharmaceuticals Main Business Overview
11.23.5 Amneal Pharmaceuticals Latest Developments
11.24 Purdue Pharmaceuticals L.P.
11.24.1 Purdue Pharmaceuticals L.P. Company Information
11.24.2 Purdue Pharmaceuticals L.P. Human Pain Management Drug Product Offered
11.24.3 Purdue Pharmaceuticals L.P. Human Pain Management Drug Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Purdue Pharmaceuticals L.P. Main Business Overview
11.24.5 Purdue Pharmaceuticals L.P. Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Human Pain Management Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Human Pain Management Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of OTC
Table 4. Major Players of Rx
Table 5. Human Pain Management Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Human Pain Management Drug Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Human Pain Management Drug Market Size Market Share by Type (2021-2026)
Table 8. Human Pain Management Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Human Pain Management Drug Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Human Pain Management Drug Market Size Market Share by Application (2021-2026)
Table 11. Global Human Pain Management Drug Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Human Pain Management Drug Revenue Market Share by Player (2021-2026)
Table 13. Human Pain Management Drug Key Players Head office and Products Offered
Table 14. Human Pain Management Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Human Pain Management Drug Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Human Pain Management Drug Market Size Market Share by Region (2021-2026)
Table 19. Global Human Pain Management Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Human Pain Management Drug Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Human Pain Management Drug Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Human Pain Management Drug Market Size Market Share by Country (2021-2026)
Table 23. Americas Human Pain Management Drug Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Human Pain Management Drug Market Size Market Share by Type (2021-2026)
Table 25. Americas Human Pain Management Drug Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Human Pain Management Drug Market Size Market Share by Application (2021-2026)
Table 27. APAC Human Pain Management Drug Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Human Pain Management Drug Market Size Market Share by Region (2021-2026)
Table 29. APAC Human Pain Management Drug Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Human Pain Management Drug Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Human Pain Management Drug Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Human Pain Management Drug Market Size Market Share by Country (2021-2026)
Table 33. Europe Human Pain Management Drug Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Human Pain Management Drug Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Human Pain Management Drug Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Human Pain Management Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Human Pain Management Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Human Pain Management Drug
Table 39. Key Market Challenges & Risks of Human Pain Management Drug
Table 40. Key Industry Trends of Human Pain Management Drug
Table 41. Global Human Pain Management Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Human Pain Management Drug Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Human Pain Management Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Human Pain Management Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. AbbVie Inc. (Allergan plc) Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 46. AbbVie Inc. (Allergan plc) Human Pain Management Drug Product Offered
Table 47. AbbVie Inc. (Allergan plc) Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. AbbVie Inc. (Allergan plc) Main Business
Table 49. AbbVie Inc. (Allergan plc) Latest Developments
Table 50. Bristol Myers Squibb Co. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 51. Bristol Myers Squibb Co. Human Pain Management Drug Product Offered
Table 52. Bristol Myers Squibb Co. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bristol Myers Squibb Co. Main Business
Table 54. Bristol Myers Squibb Co. Latest Developments
Table 55. Sanofi S.A. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 56. Sanofi S.A. Human Pain Management Drug Product Offered
Table 57. Sanofi S.A. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Sanofi S.A. Main Business
Table 59. Sanofi S.A. Latest Developments
Table 60. Boehringer Ingelheim International GmbH Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 61. Boehringer Ingelheim International GmbH Human Pain Management Drug Product Offered
Table 62. Boehringer Ingelheim International GmbH Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Boehringer Ingelheim International GmbH Main Business
Table 64. Boehringer Ingelheim International GmbH Latest Developments
Table 65. Pfizer Inc. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 66. Pfizer Inc. Human Pain Management Drug Product Offered
Table 67. Pfizer Inc. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Pfizer Inc. Main Business
Table 69. Pfizer Inc. Latest Developments
Table 70. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 71. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Product Offered
Table 72. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Main Business
Table 74. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Latest Developments
Table 75. GSK plc. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 76. GSK plc. Human Pain Management Drug Product Offered
Table 77. GSK plc. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. GSK plc. Main Business
Table 79. GSK plc. Latest Developments
Table 80. Abbott Laboratories, Inc. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 81. Abbott Laboratories, Inc. Human Pain Management Drug Product Offered
Table 82. Abbott Laboratories, Inc. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Abbott Laboratories, Inc. Main Business
Table 84. Abbott Laboratories, Inc. Latest Developments
Table 85. Novartis AG Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 86. Novartis AG Human Pain Management Drug Product Offered
Table 87. Novartis AG Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Novartis AG Main Business
Table 89. Novartis AG Latest Developments
Table 90. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 91. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Product Offered
Table 92. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Main Business
Table 94. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Latest Developments
Table 95. Sun Pharmaceutical Industries Ltd. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 96. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Product Offered
Table 97. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Sun Pharmaceutical Industries Ltd. Main Business
Table 99. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 100. Teva Pharmaceuticals Ltd. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 101. Teva Pharmaceuticals Ltd. Human Pain Management Drug Product Offered
Table 102. Teva Pharmaceuticals Ltd. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Teva Pharmaceuticals Ltd. Main Business
Table 104. Teva Pharmaceuticals Ltd. Latest Developments
Table 105. Mallinckrodt Pharmaceuticals Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 106. Mallinckrodt Pharmaceuticals Human Pain Management Drug Product Offered
Table 107. Mallinckrodt Pharmaceuticals Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Mallinckrodt Pharmaceuticals Main Business
Table 109. Mallinckrodt Pharmaceuticals Latest Developments
Table 110. Endo Pharmaceuticals Inc. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 111. Endo Pharmaceuticals Inc. Human Pain Management Drug Product Offered
Table 112. Endo Pharmaceuticals Inc. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Endo Pharmaceuticals Inc. Main Business
Table 114. Endo Pharmaceuticals Inc. Latest Developments
Table 115. Bayer AG Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 116. Bayer AG Human Pain Management Drug Product Offered
Table 117. Bayer AG Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Bayer AG Main Business
Table 119. Bayer AG Latest Developments
Table 120. F. Hoffmann-La Roche Ltd. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 121. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Product Offered
Table 122. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. F. Hoffmann-La Roche Ltd. Main Business
Table 124. F. Hoffmann-La Roche Ltd. Latest Developments
Table 125. Procter & Gamble Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 126. Procter & Gamble Human Pain Management Drug Product Offered
Table 127. Procter & Gamble Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Procter & Gamble Main Business
Table 129. Procter & Gamble Latest Developments
Table 130. AstraZeneca Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 131. AstraZeneca Human Pain Management Drug Product Offered
Table 132. AstraZeneca Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. AstraZeneca Main Business
Table 134. AstraZeneca Latest Developments
Table 135. Cardinal Health Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 136. Cardinal Health Human Pain Management Drug Product Offered
Table 137. Cardinal Health Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Cardinal Health Main Business
Table 139. Cardinal Health Latest Developments
Table 140. Perrigo Company Plc. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 141. Perrigo Company Plc. Human Pain Management Drug Product Offered
Table 142. Perrigo Company Plc. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Perrigo Company Plc. Main Business
Table 144. Perrigo Company Plc. Latest Developments
Table 145. Bausch Health Companies Inc. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 146. Bausch Health Companies Inc. Human Pain Management Drug Product Offered
Table 147. Bausch Health Companies Inc. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Bausch Health Companies Inc. Main Business
Table 149. Bausch Health Companies Inc. Latest Developments
Table 150. Viatris Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 151. Viatris Human Pain Management Drug Product Offered
Table 152. Viatris Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Viatris Main Business
Table 154. Viatris Latest Developments
Table 155. Amneal Pharmaceuticals Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 156. Amneal Pharmaceuticals Human Pain Management Drug Product Offered
Table 157. Amneal Pharmaceuticals Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Amneal Pharmaceuticals Main Business
Table 159. Amneal Pharmaceuticals Latest Developments
Table 160. Purdue Pharmaceuticals L.P. Details, Company Type, Human Pain Management Drug Area Served and Its Competitors
Table 161. Purdue Pharmaceuticals L.P. Human Pain Management Drug Product Offered
Table 162. Purdue Pharmaceuticals L.P. Human Pain Management Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Purdue Pharmaceuticals L.P. Main Business
Table 164. Purdue Pharmaceuticals L.P. Latest Developments


List of Figures
Figure 1. Human Pain Management Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Pain Management Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Human Pain Management Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Human Pain Management Drug Sales Market Share by Country/Region (2025)
Figure 8. Human Pain Management Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Human Pain Management Drug Market Size Market Share by Type in 2025
Figure 10. Human Pain Management Drug in Hospital
Figure 11. Global Human Pain Management Drug Market: Hospital (2021-2026) & ($ millions)
Figure 12. Human Pain Management Drug in Retail Pharmacy
Figure 13. Global Human Pain Management Drug Market: Retail Pharmacy (2021-2026) & ($ millions)
Figure 14. Human Pain Management Drug in Other
Figure 15. Global Human Pain Management Drug Market: Other (2021-2026) & ($ millions)
Figure 16. Global Human Pain Management Drug Market Size Market Share by Application in 2025
Figure 17. Global Human Pain Management Drug Revenue Market Share by Player in 2025
Figure 18. Global Human Pain Management Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Human Pain Management Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Human Pain Management Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Human Pain Management Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Human Pain Management Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Human Pain Management Drug Value Market Share by Country in 2025
Figure 24. United States Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Human Pain Management Drug Market Size Market Share by Region in 2025
Figure 29. APAC Human Pain Management Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Human Pain Management Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Human Pain Management Drug Market Size Market Share by Country in 2025
Figure 38. Europe Human Pain Management Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Human Pain Management Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Human Pain Management Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Human Pain Management Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Human Pain Management Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Human Pain Management Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 61. China Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 65. India Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 68. France Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Human Pain Management Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Human Pain Management Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Human Pain Management Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Human Pain Management Drug Market Size 2027-2032 ($ millions)